Nolvadex
information and resources from the National Cancer Institute
NCI Thesaurus | Nolvadex
(Other name for: tamoxifen citrate)NCI Thesaurus | Nolvadex
(Other name for: tamoxifen citrate)
tamoxifen AstraZeneca Pharmaceuticals Dec 30 1977
tamoxifen
As a single agent to delay breast cancer recurrence following total mastectomy and axillary dissection in postmenopausal women with breast cancer (T1-3, N1, M0)
AstraZeneca Pharmaceuticals Dec 03 1986
tamoxifen
Equal bioavailability of a 20 mg Nolvadex tablet taken once a day to a 10 mg Nolvadex tablet taken twice a day.
AstraZeneca Pharmaceuticals Mar 21 1994
tamoxifen
For use in premenopausal women with metastatic breast cancer as an alternative to oophorectomy or ovarian irradiation
AstraZeneca Pharmaceuticals Mar 16 1989
tamoxifen
For use in women with axillary node-negative breast cancer adjuvant therapy.
AstraZeneca Pharmaceuticals Jun 21 1990
tamoxifen
In women with DCIS, following breast surgery and radiation, Nolvadex is indicated to reduce the risk of invasive breast cancer.
AstraZeneca Pharmaceuticals Jun 29 2000
tamoxifen
Metastatic breast cancer in men.
AstraZeneca Pharmaceuticals Apr 01 1993
tamoxifen
to reduce the incidence of breast cancer in women at high risk for breast cancer
AstraZeneca Pharmaceuticals Oct 29 1998
|
|
|
|
news articles
Switching to Arimidex® Reduces Need for Invasive Diagnostic ... Mar 9, 2006
Cancer Consultants (press release), Among postmenopausal breast cancer patients with uterine abnormalities related to Nolvadex® (tamoxifen), switching to the aromatase inhibitor Arimidex ...
Clodronate® in Early Breast Cancer May Reduce Risk of Developing ... Mar 21, 2006
Cancer Consultants (press release), ...trial included 1,069 patients with early breast cancer (stages I-III) who underwent surgery, radiation therapy, chemotherapy, and Nolvadex® (tamoxifen) if ...
Phase II Trial Explores Faslodex® After Aromatase Inhibitor Mar 6, 2006
Cancer Consultants (press release), Historically, the most common hormonal treatment for estrogen receptor-positive breast cancer was an antiestrogen called Nolvadex® (tamoxifen). ...
Aromasin® Improves Breast Cancer Outcomes Without Compromising ... Feb 28, 2006
Cancer Consultants (press release), Breast cancer patients who switched to Aromasin® (exemestane) after 2-3 years of Nolvadex® (tamoxifen) reported a similar quality of life to patients who ...
Tamoxifen Effective in Premenopausal Women with Hormone-Positive ... Mar 9, 2006
Cancer Consultants (press release), According to an early on-line article published in the Journal of Clinical Oncology, the anti-estrogen agent tamoxifen (Nolvadex®) following chemotherapy ...
Thwarting further breast cancer Mar 15, 2006
Sarasota Herald-Tribune, After the surgery, I got radiation treatments, and I took Nolvadex. What are the chances that it will come back? ... You had two of them -- radiation and Nolvadex. ...
New cancer drugs reduce recurrence Mar 6, 2006
Contra Costa Times, Q: I had a lumpectomy for breast cancer. After the surgery, I got radiation treatments, and I took Nolvadex. ... You had two of them -- radiation and Nolvadex. ...
A 62-Year-Old Woman With a New Diagnosis of Breast Cancer Mar 21, 2006
Journal of American Medical Association (subscription), 40. The Austrian Breast Cancer Study Group 8/Arimidex-Nolvadex 95 (ABCSG8/ARNO95) trial randomized 3223 women who had received 2 years of adjuvant tamoxifen to ...
Lilly's Evista Data Likely Positive, Market Limited Mar 24, 2006
Forbes Anderson pointed out that AstraZeneca ultimately gave up on its attempts to create a breast cancer prevention market for tamoxifen, also known as Nolvadex. ...
Taxotere®/Platinol®/Herceptin® Effective in Locally Advanced ... Mar 22, 2006
Cancer Consultants (press release), ...surgery, followed by subsequent chemotherapy including Adriamycin® (doxorubicin) and Cytoxan® (cyclophosphamide), radiation therapy and Nolvadex® (tamoxifen ...
Take Your Pills, All Your Pills Mar 11, 2006
Gadsden Times (subscription), AstraZeneca, which sells tamoxifen under the brand name Nolvadex and another breast cancer drug, Arimidex, helped pay for a meeting of a group of cancer ...
Researchers Update Nolvadex® Prevention Trial Nov 29, 2005
Cancer Consultants (press release), ...affiliated with the National Surgical Adjuvant Breast and Bowel Project P-1 Study have reported a 7 year follow up confirming that Nolvadex (tamoxifen) lowers ...
ARIMIDEX(R) (anastrozole) Featured in Studies Evaluating Impact of ... Dec 9, 2005
Finanzen.net, NOLVADEX(R) (tamoxifen citrate) is approved for the adjuvant treatment of node-positive and node-negative early breast cancer in postmenopausal women following ...
Study Confirms Superiority of Switching to Arimidex® Following 2 ... Dec 12, 2005
Cancer Consultants (press release), ...has confirmed that switching to the aromatase inhibitor Arimidex (anastrozole) following 2-3 years of adjuvant treatment with Nolvadex (tamoxifen) improves ...
Benefit of Switching to Arimidex® After 2-3 Years of Tamoxifen ... Dec 13, 2005
Cancer Consultants (press release), ...confirmed that switching to the aromatase inhibitor Arimidex (anastrozole) after 2-3 years of adjuvant treatment with tamoxifen (Nolvadex®) improves survival ...
Toward The Future Of Cancer Prevention Dec 18, 2005
Science Daily (press release) For example, he says that tamoxifen (Nolvadex®) reduced breast cancer risk by 50 percent in the Breast Cancer Prevention Trial, and finasteride (Propecia ...
New Data Show Survival Benefit for Arimidex(TM) in Early Breast ... Dec 9, 2005
news aktuell (Pressemitteilung), ...i) SABCS - San Antonio Breast Cancer Symposium (ii) ABCSG - Austrian Breast & Colorectal Cancer Study Group, ARNO - 'Arimidex' - 'Nolvadex', ITA - Italian ...
Faslodex® Provides Clinical Benefit for Women with Breast Cancer ... Dec 1, 2005
Cancer Consultants (press release), Historically, the most common hormonal treatment for ER-positive breast cancer was an anti-estrogen called Nolvadex® (tamoxifen). ...
More Women Will Survive Breast Cancer With Arimidex (anastrozole) ... Dec 9, 2005
Finanzen.net, ...[b] The Austrian Breast & Colorectal Cancer Study Group (ABCSG) 8, the Arimidex-Nolvadex (ARNO) 95 trial, and Italian Tamoxifen Arimidex (ITA) trial. ...
Data Show Survival Benefit For Arimidex In Early Breast Cancer Dec 9, 2005
PharmaLive.com (press release), Three key international trials [ABCSG - Austrian Breast & Colorectal Cancer Study Group 8 (n = 2262), ARNO - ‘Arimidex’-‘Nolvadex’ 95 (n = 962), and ...
SABCS: A Switch to Arimidex After Two Years of Tamoxifen Improves ... Dec 10, 2005
MedPage Today, Dr. Jonat and colleagues analyzed patient data on 4,009 postmenopausal women enrolled in three studies -- Arimidex-Nolvadex (tamoxifen) 95 (ARNO 95), the ...
Survival Benefit For Arimidexâ„¢ In Early Breast Cancer Dec 11, 2005
Medical News Today (press release), Three key international trials [ABCSG - Austrian Breast & Colorectal Cancer Study Group 8 (n = 2262), ARNO - ‘Arimidex'-‘Nolvadex' 95 (n = 962), and ITA ...
Canadian Regulators Warn Against Use of Femara as Fertility Drug Nov 30, 2005
CNN Extended adjuvant treatment of early breast cancer in postmenopausal women who have received five years of adjuvant therapy with Nolvadex (tamoxifen). ...
Updated Results Confirm Tamoxifen Risks and Benefits Nov 21, 2005
Cancer Consultants (press release), Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial (P-1) began in 1992, with the goal of determining whether tamoxifen (Nolvadex®) could reduce ...
AstraZeneca Provides Additional Support to Hurricane Victims Nov 17, 2005
PR Newswire (press release), ...rosuvastatin calcium), EMLA Cream (lidocaine 2.5% and prilocaine 2.5%), FASLODEX(R) (fulvestrant), NEXIUM(R) (esomeprazole magnesium), NOLVADEX(R) (tamoxifen ...
|
|
